Simon Campion
Chief Executive Officer bei DENTSPLY SIRONA INC.
Vermögen: 10 Mio $ am 31.03.2024
Profil
Simon D.
Campion is currently the Chief Executive Officer at Medafor, Inc., Y-Med, Inc., and Lutonix, Inc. He is also the President at Vascular Pathways, Inc. and SenoRx, Inc. In 2022, he became the President, Chief Executive Officer & Director at Dentsply Sirona, Inc. Previously, he worked as the Director-Global Marketing at C.
R.
Bard, Inc. from 2008 to 2017.
He then worked as the President-Medical Segment & Executive VP at Becton, Dickinson & Co. from 2017 to 2022.
He was also the President at Liberator Medical Holdings, Inc. Dr. Campion holds an MBA from The Open University and an undergraduate and doctorate degree from the University of Limerick.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DENTSPLY SIRONA, INC.
0,14% | 12.04.2024 | 291 463 ( 0,14% ) | 10 Mio $ | 31.03.2024 |
Aktive Positionen von Simon Campion
| Unternehmen | Position | Beginn |
|---|---|---|
| DENTSPLY SIRONA INC. | Chief Executive Officer | 12.09.2022 |
Medafor, Inc.
 Medafor, Inc. Medical SpecialtiesHealth Technology Medafor, Inc. develops and manufactures medical hemostatic technology. It offers AristaAH, an absorbable surgical hemostat product that is used in the control of profuse bleeding in general surgery; FlexiTip, a spray applicator for the management of bleeding or profuse following topical ENT surgical procedures; and TraumaDEX, a topical dressing for the control of severely bleeding wounds from traumatic injuries, including cuts, lacerations, and puncture wounds. The company was founded in 1999 and is headquartered in Minneapolis, MN. | Chief Executive Officer | - |
Y-Med, Inc.
 Y-Med, Inc. Medical SpecialtiesHealth Technology Y-Med, Inc. develops and manufactures medical devices for vascular intervention providing less invasive therapies for a broad range of circulatory diseases. The company was founded in 2004 and is headquartered in San Diego, CA. | Chief Executive Officer | - |
Vascular Pathways, Inc.
 Vascular Pathways, Inc. Medical SpecialtiesHealth Technology Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ. | President | - |
SenoRx, Inc.
 SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | President | - |
Lutonix, Inc.
 Lutonix, Inc. Medical SpecialtiesHealth Technology Lutonix, Inc. develops and commercializes drug coated balloon catheters. Its catheters help to deliver therapeutic dose of paclitaxel. The firm’s catheters are used to treat peripheral and coronary lesions. The company was founded in July 2007 by Dennis Wahr and Lixiao Wang and is headquartered in New Hope, MN. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Simon Campion
| Unternehmen | Position | Ende |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 09.09.2022 |
| C.R. BARD | Sales & Marketing | 01.12.2017 |
| LIBERATOR MEDICAL HOLDINGS INC | President | - |
Ausbildung von Simon Campion
| The Open University | Masters Business Admin |
| University of Limerick | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| DENTSPLY SIRONA INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Liberator Medical Holdings, Inc.
 Liberator Medical Holdings, Inc. Specialty StoresRetail Trade Liberator Medical Holdings, Inc. operates as a holding company, which through its subsidiaries, provides medical supplies primarily to medicare-eligible seniors. It bill medicare and third-party insurers on behalf of its patients. The company is headquartered in Stuart, FL. | Retail Trade |
Medafor, Inc.
Medafor, Inc. Medical SpecialtiesHealth Technology Medafor, Inc. develops and manufactures medical hemostatic technology. It offers AristaAH, an absorbable surgical hemostat product that is used in the control of profuse bleeding in general surgery; FlexiTip, a spray applicator for the management of bleeding or profuse following topical ENT surgical procedures; and TraumaDEX, a topical dressing for the control of severely bleeding wounds from traumatic injuries, including cuts, lacerations, and puncture wounds. The company was founded in 1999 and is headquartered in Minneapolis, MN. | Health Technology |
Y-Med, Inc.
Y-Med, Inc. Medical SpecialtiesHealth Technology Y-Med, Inc. develops and manufactures medical devices for vascular intervention providing less invasive therapies for a broad range of circulatory diseases. The company was founded in 2004 and is headquartered in San Diego, CA. | Health Technology |
Vascular Pathways, Inc.
Vascular Pathways, Inc. Medical SpecialtiesHealth Technology Vascular Pathways, Inc. develops and commercializes vascular access devices. Its product, AccuCath Intravenous Catheter is a peripheral catheter technology designed to provide acces to veins. It has an AccuTip nitinol guidewire that creates a pathway within the vessel and deploys the catheter atraumatically. The company was founded by Amir Belson in 2005 and is headquartered in Franklin Lakes, NJ. | Health Technology |
SenoRx, Inc.
SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Health Technology |
Lutonix, Inc.
Lutonix, Inc. Medical SpecialtiesHealth Technology Lutonix, Inc. develops and commercializes drug coated balloon catheters. Its catheters help to deliver therapeutic dose of paclitaxel. The firm’s catheters are used to treat peripheral and coronary lesions. The company was founded in July 2007 by Dennis Wahr and Lixiao Wang and is headquartered in New Hope, MN. | Health Technology |
